Lymphadenopathy of IgG4-related disease: An underdiagnosed and overdiagnosed entity

Seminars in Diagnostic Pathology

Volumn 29, Issue 4, 2012, Pages 226-234

  Cheuk, Wah ^a   Chan, John K C ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Hyperplasia; ; IgG4 related; IgG4 related disease; ; Inflammatory; Lymphadenopathy; ; Paracortical; Progressive; Pseudotumor; Transformation of germinal centers;

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANTIBODY TITER; ARTICLE; BLOOD PROTEIN DISORDER; CELL INFILTRATION; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EOSINOPHIL; ERYTHROCYTE SEDIMENTATION RATE; HISTOPATHOLOGY; HUMAN; IMMUNOBLAST; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHADENOPATHY; LYMPHOID HYPERPLASIA; MORBIDITY; MORPHOLOGY; MORTALITY; PRIORITY JOURNAL;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; GERMINAL CENTER; GIANT LYMPH NODE HYPERPLASIA; HUMANS; IMMUNOGLOBULIN G; LYMPH NODES; LYMPHATIC DISEASES; LYMPHOMA, T-CELL;

EID: 84867473460     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2012.07.001     Document Type: Article

References (31)

1. Kamisawa T., Egawa N., Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003, 98:2811-2812.
2. Kamisawa T., Nakajima H., Egawa N., et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006, 6:132-137.
3. Cheuk W., Chan J.K. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010, 17:303-332.
4. Deshpande V., Zen Y., Chan J.K., et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012, 25:1181-1192.
5. Umehara H., Okazaki K., Masaki Y., et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol 2012, 22:21-30.
6. Stone J.H., Zen Y., Deshpande V. IgG4-related disease. N Engl J Med 2012, 366:539-551.
7. Stone J.H., Khosroshahi A., Deshpande V., et al. IgG4-related disease: recommendations for the nomenclature of this condition and its individual organ system manifestations. Arthritis Rheum 2012, [Epub ahead of print].
8. Hamano H., Arakura N., Muraki T., et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006, 41:1197-1205.
9. Cheuk W., Yuen H.K., Chu S.Y., et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 2008, 32:671-681.
10. Cheuk W., Chan J.K. Lymphoproliferative lesions in IgG4-related disease. Curr. Immunol Rev 2011, 7:221-231.
11. Sato Y., Kojima M., Takata K., et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol 2009, 22:589-599.
12. Sato Y., Notohara K., Kojima M., et al. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 2010, 60:247-258.
13. Sato Y., Yoshino T. IgG4-related lymphadenopathy. Int J Rheumatol 2012, 2012. 572539.
14. Grimm K.E., Barry T.S., Chizhevsky V., et al. Histopathological findings in 29 lymph node biopsies with increased IgG4 plasma cells. Mod Pathol 2012, 25:480-491.
15. Sato Y., Inoue D., Asano N., et al. Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes. Mod Pathol 2012, 25:956-967.
16. Kojima M., Miyawaki S., Takada S., et al. Lymphoplasmacytic infiltrate of regional lymph nodes in Kuttner's tumor (chronic sclerosing sialadenitis): a report of 3 cases. Int J Surg Pathol 2008, 16:263-268.
17. Shimizu I., Nasu K., Sato K., et al. Lymphadenopathy of IgG4-related sclerosing disease: three case reports and review of literature. Int J Hematol 2010, 92:751-756.
18. Koo C.H., Nathwani B.N., Winberg C.D., et al. Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmune-disease-associated lymphadenopathy). Medicine (Baltimore) 1984, 63:274-290.
19. Segal G.H., Clough J.D., Tubbs R.R. Autoimmune and iatrogenic causes of lymphadenopathy. Semin Oncol 1993, 20:611-626.
20. Takahashi E., Kojima M., Kobayashi M., et al. Primary IgG4-related lymphadenopathy with prominent granulomatous inflammation and reactivation of Epstein-Barr virus. Virchows Arch 2012, 460:225-229.
21. Siddiqi I.N., Brynes R.K., Grimm K., et al. Perifollicular granulomatous inflammation in reactive lymph node: a potential morphologic marker for IgG4 plasmacytosis. Hematol Pathol 2011, 4:207-214.
22. Burns B.F., Colby T.V., Dorfman R.F. Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers. Am J Surg Pathol 1984, 8:253-261.
23. + plasma cells: a case mimicking IgG4-related disease. J Clin Exp Hematop 2012, 52:57-61.
24. Rollins-Raval M.A., Felgar R.E., Krasinskas A.M., et al. Increased numbers of IgG4-positive plasma cells may rarely be seen in lymph nodes of patients without IgG4-related sclerosing disease. Int J Surg Pathol 2012, 20:47-53.
25. Sato Y., Kojima M., Takata K., et al. Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol 2010, 63:1084-1089.
26. Okazaki K., Kawa S., Kamisawa T., et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006, 41:626-631.
27. Hamano H., Kawa S., Horiuchi A., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344:732-738.
28. Kamisawa T., Okamoto A., Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas 2005, 31:28-31.
29. Okazaki K., Umehara H. Are classification criteria for IgG4-RD now possible?. The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan. Int J Rheumatol 2012, 2012. 357071.
30. Peterson B.A., Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993, 20:636-647.
31. Nishimoto N., Sasai M., Shima Y., et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 2000, 95:56-61.